DexCare, Inc

Genelex Corporation, based in Seattle, WA, has been a leader in genetic testing and molecular diagnostics for over 30 years, specializing in pharmacogenetics (PGx). The company offers a comprehensive pharmacogenetic test that analyzes how a patient's genes affect their response to medications, aiming to enhance personalized medicine. As a CLIA-certified laboratory, Genelex emphasizes adherence to best practices, providing accurate results supported by clinical validity and ongoing customer support. Their innovative approach combines advanced analytics, state-of-the-art laboratory facilities, and expert staff to assist healthcare providers in optimizing medication management and minimizing adverse drug events. Generated from the website

Novo Nordisk, a global healthcare company headquartered in Seattle, WA, is dedicated to shaping treatments and improving patient outcomes in disease areas such as cardiovascular health and obesity. With a commitment to sustainable business practices and innovation, Novo Nordisk's sales have shown significant growth, reflecting their impact in the healthcare industry. Recently, Novo Nordisk's product, Wegovy, received FDA approval for reducing cardiovascular risk in adults with heart disease and obesity, showcasing the company's focus on addressing critical health issues. As a leader in the field, Novo Nordisk continues to expand its reach and make a difference in healthcare through its dedication to patient care and employee well-being. Generated from the website

Artefact is a Seattle-based strategy design firm that specializes in helping clients define the future through responsible design. Their expert team works closely with businesses to create innovative strategies and solutions that drive success and positive impact. Generated from their website's infomation